RAPTIVA SubQ
Generic Name: EFALIZUMAB - SUBCUTANEOUS INJECTIONPronounced: (e-fal-IZ-oo-mab)
RAPTIVA SubQ Warning
Efalizumab decreases immune system function (immunosuppression), which can result in very serious (possibly fatal) infections (e.g., tuberculosis, meningitis, PML), or a worsening of an existing infection. Seek immediate medical attention if you develop signs of serious infection such as persistent fever/cough, difficulty breathing, confusion, loss of balance, sudden vision/speech problems.
RAPTIVA SubQ Side Effects
See also Warning section.
Headache, chills, fever, nausea, vomiting, or muscle aches may occur during the first weeks, but then subside as your body adjusts to this medication. Pain, acne, backache, weakness, or flu-like symptoms may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Tell your doctor immediately if any of these serious side effects occur:
- joint pain or swelling
- swelling of hands or feet
Tell your doctor immediately if any of these highly unlikely but very serious side effects occur:
- unusual bleeding or bruising
- unusual lumps
- swollen glands
- changes in skin appearance other than psoriasis-affected areas
- yellowing of eyes/skin
- dark urine
- dizziness upon standing
- sudden numbness/tingling/weakness
A serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction include:
- rash
- itching/swelling (especially of the face/tongue/throat)
- dizziness
- trouble breathing
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
Call your doctor for medical advice about side effects. In the US, you may report side effects to the Food and Drug Administration (FDA) at 1-800-FDA-1088.
In Canada, you may report side effects to Health Canada at 1-866-234-2345.
RAPTIVA SubQ Medical Alert
Your condition can cause complications in a medical emergency. For enrollment information call MedicAlert at 1-800-854-1166 (USA) or 1-800-668-1507 (Canada).
Previous Section
